DNA-testing firm 23andMe goes public via Branson-backed SPAC
CEO Anne Wojcicki says Covid-19 has opened doors to more health-care products including genetic data
04 February 2021 - 20:21
Consumer DNA-testing company 23andMe has entered into a deal to merge with VG Acquisition, a special purpose acquisition company founded by billionaire Richard Branson.
The agreement values the Silicon Valley company at $3.5bn, with CEO Anne Wojcicki and Branson each investing $25m into a $250m private investment in public equity offering. Bloomberg News reported news of a potential deal last week...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.